Brief: Cesca Therapeutics Q1 Loss Per Share $0.08
May 14 (Reuters) - Cesca Therapeutics Inc KOOL.O :
* CESCA THERAPEUTICS ANNOUNCES FIRST QUARTER 2019 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q1 LOSS PER SHARE $0.08
* Q1 REVENUE ROSE 59 PERCENT TO $3.0 MILLION
Source text for Eikon: ID:nPn3f34Gfa
Further company coverage: KOOL.O
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Thermogenesis Holdings
See all newsThermogenesis Holdings Inc expected to post earnings of 1 cent a share - Earnings Preview
Thermogenesis Holdings Inc reports results for the quarter ended in December - Earnings Summary
Thermogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview
Thermogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview
Brief: Thermogenesis Holdings Says On Jan 8 Co Received Nasdaq Letter Notifying It No Longer Complies With Minimum Bid Price Requirement For Listing On Nasdaq